Hippocampal volumes, proton magnetic resonance spectroscopy metabolites, and cerebrovascular disease in mild cognitive impairment subtypes
- PMID: 19064749
- PMCID: PMC2743393
- DOI: 10.1001/archneur.65.12.1621
Hippocampal volumes, proton magnetic resonance spectroscopy metabolites, and cerebrovascular disease in mild cognitive impairment subtypes
Abstract
Background: Although a majority of patients with amnestic mild cognitive impairment (aMCI) progress to Alzheimer disease, the natural history of nonamnestic MCI (naMCI) is less clear. Noninvasive imaging surrogates for underlying pathological findings in MCI would be clinically useful for identifying patients who may benefit from disease-specific treatments at the prodromal stage of dementia.
Objective: To determine the characteristic magnetic resonance imaging (MRI) and proton MR spectroscopy (1H MRS) profiles of MCI subtypes.
Design: Case-control study.
Setting: Community-based sample at a tertiary referral center.
Patients: Ninety-one patients with single-domain aMCI, 32 patients with multiple-domain aMCI, 20 patients with single- or multiple-domain naMCI, and 100 cognitively normal elderly subjects frequency-matched by age and sex.
Main outcome measures: Posterior cingulate gyrus 1H MRS metabolite ratios, hippocampal volumes, and cerebrovascular disease on MRI.
Results: Patients with single-domain aMCI were characterized by small hippocampal volumes and elevated ratios of myo-inositol to creatine levels. Patients with naMCI on average had normal hippocampal volumes and 1H MRS metabolite ratios, but a greater proportion (3 of 20 patients [15%]) had cortical infarctions compared with patients with single-domain aMCI (6 of 91 [7%]). For characterization of MCI subtypes, 1H MRS and structural MRI findings were complementary.
Conclusions: The MRI and 1H MRS findings in single-domain aMCI are consistent with a pattern similar to that of Alzheimer disease. Absence of this pattern on average in patients with naMCI suggests that cerebrovascular disease and other neurodegenerative diseases may be contributing to the cognitive impairment in many individuals with naMCI.
Figures

Similar articles
-
Risk of dementia in MCI: combined effect of cerebrovascular disease, volumetric MRI, and 1H MRS.Neurology. 2009 Apr 28;72(17):1519-25. doi: 10.1212/WNL.0b013e3181a2e864. Neurology. 2009. PMID: 19398707 Free PMC article.
-
Using proton magnetic resonance spectroscopy to identify mild cognitive impairment.Int Psychogeriatr. 2012 Jan;24(1):19-27. doi: 10.1017/S1041610211000962. Epub 2011 Jun 16. Int Psychogeriatr. 2012. PMID: 21676281
-
Characteristic early changes of Glu and Cho in brain regions affected by different types of subjective cognitive decline and their clinical significance.Medicine (Baltimore). 2023 Dec 8;102(49):e36457. doi: 10.1097/MD.0000000000036457. Medicine (Baltimore). 2023. PMID: 38065860 Free PMC article.
-
Hippocampal metabolic abnormalities in mild cognitive impairment and Alzheimer's disease.Neurosci Lett. 2005 Aug 12-19;384(1-2):23-8. doi: 10.1016/j.neulet.2005.04.035. Neurosci Lett. 2005. PMID: 15905028
-
Proton MRS in mild cognitive impairment.J Magn Reson Imaging. 2013 Apr;37(4):770-7. doi: 10.1002/jmri.23800. J Magn Reson Imaging. 2013. PMID: 23526756 Free PMC article. Review.
Cited by
-
Effects of age on the glucose metabolic changes in mild cognitive impairment.AJNR Am J Neuroradiol. 2010 Aug;31(7):1247-53. doi: 10.3174/ajnr.A2070. Epub 2010 Mar 18. AJNR Am J Neuroradiol. 2010. PMID: 20299441 Free PMC article. Clinical Trial.
-
Selective worsening of brain injury biomarker abnormalities in cognitively normal elderly persons with β-amyloidosis.JAMA Neurol. 2013 Aug;70(8):1030-8. doi: 10.1001/jamaneurol.2013.182. JAMA Neurol. 2013. PMID: 23797806 Free PMC article.
-
Similar verbal fluency patterns in amnestic mild cognitive impairment and Alzheimer's disease.Arch Clin Neuropsychol. 2013 Aug;28(5):400-10. doi: 10.1093/arclin/act039. Epub 2013 Jun 9. Arch Clin Neuropsychol. 2013. PMID: 23752677 Free PMC article.
-
Association of Kidney Function Biomarkers with Brain MRI Findings: The BRINK Study.J Alzheimers Dis. 2017;55(3):1069-1082. doi: 10.3233/JAD-160834. J Alzheimers Dis. 2017. PMID: 27767995 Free PMC article.
-
Current understanding of magnetic resonance imaging biomarkers and memory in Alzheimer's disease.Alzheimers Dement (N Y). 2018 Jun 14;4:395-413. doi: 10.1016/j.trci.2018.04.007. eCollection 2018. Alzheimers Dement (N Y). 2018. PMID: 30229130 Free PMC article. Review.
References
-
- Petersen RC. Mild cognitive impairment. Continuum. 2004;10(1):9–28.
-
- Fischer P, Jungwirth S, Zehetmayer S, et al. Conversion from subtypes of mild cognitive impairment to Alzheimer dementia. Neurology. 2007;68(4):288–291. - PubMed
-
- Flicker C, Ferris SH, Reisberg B. Mild cognitive impairment in the elderly: predictors of dementia. Neurology. 1991;41(7):1006–1009. - PubMed
-
- Morris JC, Storandt M, Miller JP, et al. Mild cognitive impairment represents early-stage Alzheimer disease. Arch Neurol. 2001;58(3):397–405. - PubMed
-
- Busse A, Hensel A, Guhne U, Angermeyer MC, Riedel-Heller SG. Mild cognitive impairment: long-term course of four clinical subtypes. Neurology. 2006;67(12):2176–2185. - PubMed